12:00 AM
Feb 27, 2006
 |  BioCentury  |  Finance

More buybacks

More buybacks

Amgen's latest stock repurchase plan indicates the company continues to generate more cash than it can invest for future growth. In...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >